![](/imager/uploads/Companies/Rocket-Lab/40183/50276607898_28114ea3c2_o_6439e647a38ed5b4d852739476ebaac9.webp)
![](/imager/uploads/Companies/Totus-Meds/44977/PXL_20230322_212054876_6439e647a38ed5b4d852739476ebaac9.webp)
![](/uploads/logos/_logo_h/Totus-White-Logo.png)
First Investment: 2020
Many diseases have been considered untreatable because there are no known molecules that can interrupt the given underlying biomolecular pathways. Totus uses high-throughput cell-based assays and large-scale machine learning to screen the activity of billions of compounds across the entire human genome, yielding new covalent drugs that can irreversibly bind to disease-causing proteins and silence them.
News & Insights
![](/imager/uploads/Companies/Rocket-Lab/40183/50276607898_28114ea3c2_o_6439e647a38ed5b4d852739476ebaac9.webp)
DCVC Announcements
In The Media
Explore Companies
![](/imager/uploads/logos/58681/Avicenna_logo_black_117378e58441a39758ec294c229f7090.webp)
Avicenna Biosciences
Using AI to speed through the last mile of drug discovery
![](/imager/uploads/logos/58643/latus-logo-copy_117378e58441a39758ec294c229f7090.webp)
![](/imager/uploads/Companies/Latus/58650/Latus-lab_6439e647a38ed5b4d852739476ebaac9.webp)
Latus Bio
Finding precisely tuned viral vectors for gene therapy in CNS disorders
![](/imager/uploads/logos/57002/radionetics-logo_black_117378e58441a39758ec294c229f7090.webp)
![](/imager/uploads/Companies/Radionetics/57003/Radionetics_6439e647a38ed5b4d852739476ebaac9.webp)
Radionetics Oncology
Discovering more precise ways to deploy radiopharmaceuticals against solid tumors
![](/imager/uploads/logos/55895/DVLP-logo-black_117378e58441a39758ec294c229f7090.webp)
DVLP Medicines
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing